Healium Medical Ltd. announced a new collaboration and licensing agreement with Broncus Holding Corporation. Broncus specializes in interventional diagnostic tools and treatments for pulmonary diseases by using ablation energy modalities including radiofrequency and thermal vapor. The cooperation integrates Broncus's energy ablation with Healium's ultrasound technology to advance lung cancer treatment by allowing operators in real-time to target, treat and monitor ablated tissues with a single tool.

The new technology is expected to deliver more predictable treatment outcomes with increased safety and efficacy while simplifying the procedure flow for interventional pulmonologists.